RxDoctor Payments Data

Cara Cockerill, MD

Otolaryngology · Albert Lea, MNNPI 1033404082

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations.

$1,448in general payments, 2019–2025

Across 34 payments — averaging $42.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$328
  • Inspire Medical Systems, Inc.$238
  • Cochlear Americas$167
  • Arrinex, Inc.$147
  • Acclarent, Inc$136
  • Boston Scientific$131
  • plus $302 from 9 others

What the payments were for

  • Food & beverage$1,448100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,448 in reported general payments places this provider in the 65th percentile of 181 otolaryngology providers in Minnesota.

See all otolaryngology providers in Minnesota

Medicare billing

Part B allowed, 2024
$137,984
Medicare patients
395
Services billed
1,922

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Epinephrine12$2,365
Azelastine Hcl48$1,367
Ofloxacin37$663
Ipratropium Bromide15$434
Pantoprazole Sodium28$207
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$183
Omeprazole22$149

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Albert Lea

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →